| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |